Skip to content
Parakho

Sanjivani Paranteral Ltd

BSE 531569sanjivani.co.in

Statement of profit and loss

Parakho has not ingested a filed result for this company on a consolidated basis. When the company files one with the exchange, it appears here automatically.

Earnings call

Q4 FY26

Sanjivani Paranteral reported a year-on-year decline in Q4 FY26 revenue after Iran-related geopolitical disruptions halted Middle East export shipments during March 2026, while raw material and packing input costs also rose during the quarter. Standalone Q4 revenue was INR 105.1 million with EBITDA margin of 14.7%, and consolidated revenue was INR 132.1 million with EBITDA margin of 15.74%. Management said alternate logistics routes have been established and expects export recovery in Q1 FY27, alongside continued ramp-up of the Pune IV fluids facility and the Prague nutraceutical joint venture.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 37 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 24 Aug 2026.